BeOne Medicines Ltd. (06160) Announces New Loan Facilities Agreement with HSBC

Bulletin Express11-19

BeOne Medicines Ltd. (Stock Code: 06160) announced the entry into a Facilities Agreement on November 13, 2025, with The Hongkong and Shanghai Banking Corporation Limited (HSBC) and a syndicate of lenders. Under this agreement, BeOne Medicines Ltd. gains access to three distinct loan facilities:

The B Loan Facilities comprise (i) a US-dollar-denominated revolving loan facility of US$140 million (B1) and (ii) a US-dollar-denominated term loan facility of US$560 million (B2). These collectively amount to US$700 million and include an uncommitted option that could allow the B Loan Facilities to increase, subject to the agreement's outlined conditions. Additionally, a Renminbi-denominated A Loan Facility provides approximately RMB300 million.

The Facilities Agreement designates that proceeds may be used for general corporate obligations, refinancing existing debt, and financing related fees and expenses. The loan package features varying interest rates, which apply a margin of 0.65% per annum above the RMB reference rate for the A Loan Facility and 2.40% per annum above the USD reference rate for the B Loan Facilities. The arrangement also includes standard covenants on repayment schedules, security interests, guarantees, and conditions precedent, as well as customary events of default.

According to the announcement, the initial utilization of any loan facility depends on satisfying the agreement’s conditions precedent, including required regulatory approvals. The Facilities Agreement specifies that all obligations under these loan facilities are secured by certain assets of BeOne Medicines Ltd. and several guarantors within the group.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1157220588?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-19 20:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157220588","market":"us","top_or_hot":-1,"title":"BeOne Medicines Ltd. (06160) Announces New Loan Facilities Agreement with HSBC","media":"Bulletin Express","content":"<p>BeOne Medicines Ltd. (Stock Code: 06160) announced the entry into a Facilities Agreement on November 13, 2025, with The Hongkong and Shanghai Banking Corporation Limited (HSBC) and a syndicate of lenders. Under this agreement, BeOne Medicines Ltd. gains access to three distinct loan facilities:</p>\n<p>The B Loan Facilities comprise (i) a US-dollar-denominated revolving loan facility of US$140 million (B1) and (ii) a US-dollar-denominated term loan facility of US$560 million (B2). These collectively amount to US$700 million and include an uncommitted option that could allow the B Loan Facilities to increase, subject to the agreement's outlined conditions. Additionally, a Renminbi-denominated A Loan Facility provides approximately RMB300 million.</p>\n<p>The Facilities Agreement designates that proceeds may be used for general corporate obligations, refinancing existing debt, and financing related fees and expenses. The loan package features varying interest rates, which apply a margin of 0.65% per annum above the RMB reference rate for the A Loan Facility and 2.40% per annum above the USD reference rate for the B Loan Facilities. The arrangement also includes standard covenants on repayment schedules, security interests, guarantees, and conditions precedent, as well as customary events of default.</p>\n<p>According to the announcement, the initial utilization of any loan facility depends on satisfying the agreement’s conditions precedent, including required regulatory approvals. The Facilities Agreement specifies that all obligations under these loan facilities are secured by certain assets of BeOne Medicines Ltd. and several guarantors within the group.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BeOne Medicines Ltd. (06160) Announces New Loan Facilities Agreement with HSBC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeOne Medicines Ltd. (06160) Announces New Loan Facilities Agreement with HSBC\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-19 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BeOne Medicines Ltd. (Stock Code: 06160) announced the entry into a Facilities Agreement on November 13, 2025, with The Hongkong and Shanghai Banking Corporation Limited (HSBC) and a syndicate of lenders. Under this agreement, BeOne Medicines Ltd. gains access to three distinct loan facilities:</p>\n<p>The B Loan Facilities comprise (i) a US-dollar-denominated revolving loan facility of US$140 million (B1) and (ii) a US-dollar-denominated term loan facility of US$560 million (B2). These collectively amount to US$700 million and include an uncommitted option that could allow the B Loan Facilities to increase, subject to the agreement's outlined conditions. Additionally, a Renminbi-denominated A Loan Facility provides approximately RMB300 million.</p>\n<p>The Facilities Agreement designates that proceeds may be used for general corporate obligations, refinancing existing debt, and financing related fees and expenses. The loan package features varying interest rates, which apply a margin of 0.65% per annum above the RMB reference rate for the A Loan Facility and 2.40% per annum above the USD reference rate for the B Loan Facilities. The arrangement also includes standard covenants on repayment schedules, security interests, guarantees, and conditions precedent, as well as customary events of default.</p>\n<p>According to the announcement, the initial utilization of any loan facility depends on satisfying the agreement’s conditions precedent, including required regulatory approvals. The Facilities Agreement specifies that all obligations under these loan facilities are secured by certain assets of BeOne Medicines Ltd. and several guarantors within the group.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1157220588","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157220588","pubTimestamp":1763553842,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"BeOne Medicines Ltd. (Stock Code: 06160) announced the entry into a Facilities Agreement on November 13, 2025, with The Hongkong and Shanghai Banking Corporation Limited (HSBC) and a syndicate of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"BeOne Medicines Ltd.(06160)宣布与汇丰银行签订新贷款融资协议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"BeOne Medicines Ltd. (Stock Code: 06160) announced the entry into a Facilities Agreement on November 13, 2025, with The Hongkong and Shanghai Banking Corporation Limited (HSBC) and a syndicate of lenders. Under this agreement, BeOne Medicines Ltd. gains access to three distinct loan facilities:\nThe B Loan Facilities comprise (i) a US-dollar-denominated revolving loan facility of US$140 million (B1) and (ii) a US-dollar-denominated term loan facility of US$560 million (B2). These collectively amount to US$700 million and include an uncommitted option that could allow the B Loan Facilities to increase, subject to the agreement's outlined conditions. Additionally, a Renminbi-denominated A Loan Facility provides approximately RMB300 million.\nThe Facilities Agreement designates that proceeds may be used for general corporate obligations, refinancing existing debt, and financing related fees and expenses. The loan package features varying interest rates, which apply a margin of 0.65% per annum above the RMB reference rate for the A Loan Facility and 2.40% per annum above the USD reference rate for the B Loan Facilities. The arrangement also includes standard covenants on repayment schedules, security interests, guarantees, and conditions precedent, as well as customary events of default.\nAccording to the announcement, the initial utilization of any loan facility depends on satisfying the agreement’s conditions precedent, including required regulatory approvals. The Facilities Agreement specifies that all obligations under these loan facilities are secured by certain assets of BeOne Medicines Ltd. and several guarantors within the group.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1157220588","isCrawlerRequest":true}